Thursday, July 7, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Cancer

Research brief: Improving rug efficacy against prostate cancer and related bone growths

April 20, 2021
in Cancer
0
Share on FacebookShare on Twitter

Published in the Advanced Functional Materials, University of Minnesota researcher Hongbo Pang led a cross-institutional study on improving the efficacy of nucleotide-based drugs against prostate cancer and bone metastasis.

In this study, Pang and his research team looked at whether liposomes, when integrated with the iRGD peptide, will help concentrate antisense oligonucleotides (ASOs) into primary prostate tumors and its bone metastases. Liposomes are used as a drug carrier system, and ASOs are a type of nucleotide drug.

More importantly, they investigated whether this system helps more drugs across the vessel wall and deeply into the tumor tissue. This is critical because, although nucleotide drugs offer unique advantages in treating tumors and other diseases, they often suffer from a poor efficiency of crossing the blood vessels and entering the tumor tissue, where their targets reside. This problem greatly limits their clinical applicability and efficacy.

“Our system demonstrates a good ability to deliver more ASOs into both primary tumor tissue and bone metastases — which is the primary site for prostate cancer metastasis,” said Pang, an assistant professor in the College of Pharmacy and a member of the Masonic Cancer Center. “This further translates into a significant improvement of ASO efficacy to inhibit the growth of primary tumor and bone metastases. We expect this system to become a universal carrier system, to improve the clinical efficacy of ASOs and other nucleotide drugs.”

The study found that:

  • iRGD-liposomes can increase the tumor accumulation and vascular/tissue penetration of ASOs against the disease-driving gene of prostate cancer;
  • the ability of ASOs to inhibit the growth of both primary tumors and bone metastases was significantly enhanced by iRGD-liposomes;
  • and, a long-term tumor inhibition study was also performed, showing that iRGD-liposomes significantly prolongs the AR-ASO suppression of primary tumor growth.

Pang and his team say that iRGD-liposomes are proven as a desirable delivery system for ASOs, and hold the promise to improve the clinical efficacy of nucleotide drugs in cancer therapies.

###

This study was funded by the National Institute of Health and the State of Minnesota.

Media Contact
Kat Dodge
[email protected]

Related Journal Article

https://twin-cities.umn.edu/news-events/improving-rug-efficacy-against-prostate-cancer-and-related-bone-growths
http://dx.doi.org/10.1002/adfm.202100478

Tags: Medicine/HealthPharmaceutical SciencePharmaceutical SciencesPharmaceutical/Combinatorial ChemistryProstate Cancer
Share25Tweet16Share4ShareSendShare
  • PAN protein domain

    Scientists discover cancer trigger that could spur targeted drug therapies

    79 shares
    Share 32 Tweet 20
  • COVID-19 fattens up our body’s cells to fuel its viral takeover

    103 shares
    Share 41 Tweet 26
  • Messenger RNA technology shows promise for developing infectious disease therapeutics

    66 shares
    Share 26 Tweet 17
  • Killing resistant prostate cancer with iron

    66 shares
    Share 26 Tweet 17
  • ‘Supergene’ wreaks havoc in a genome

    65 shares
    Share 26 Tweet 16
  • How bilingual brains work: Cross-language interplay and an integrated lexicon

    65 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

COVID-19 fattens up our body’s cells to fuel its viral takeover

Scientists discover cancer trigger that could spur targeted drug therapies

Immune molecules from a llama could provide protection against a vast array of SARS-like viruses including COVID-19, researchers say

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 190 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....